![]() After adjusting for a restructuring effort, the integration of its $800 million buyout of Olympus Corp.’s diagnostics division and amortization of some Olympus assets, adjusted diluted EPS were $1.00 per share, up 12.4 percent from 89 cents per adjusted diluted share during Q3 2009. ![]() That compares with earnings of $1.5 million, or 2 cents per share, on sales of $822.8 million during the same period last year.īut don’t let that 4,366 percent bottom-line spike fool you. The Orange County, Calif.-based medical device and diagnostics maker reported net earnings of $67.0 million, or 95 cents per share, on sales of $893.8 million during the three months ended Sept. ![]() (NYSE: BEC) reaffirmed its 2010 guidance after posting sales and earnings increases during the third quarter. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
January 2023
Categories |